Abstract: In a Gas Tungsten Arc or Gas Metal Arc welding method for austenitic steel that does not contain Ti or Al in a respective quantity of more than about 0.2% by weight, a welding additive containing Ti and/or Al is used in conjunction with a welding gas that contains nitrogen.

Abstract: A method for arc joining, in particular for M[etal]S[hielding]G[as] welding and/or for M[etal]S[hielding]G[as] soldering of at least one object made of titanium and/or of at least a titanium alloy under shielding gas in the presence of at least one melting electrode, wherein at least an inert gas is supplied as shielding gas in such a manner that the arc burns in a stable and calm manner in response to the arc joining. The shielding gas further includes at least one active gas.

Abstract: Disclosed is a process for the manufacture of pseudo proline dipeptides of the formula wherein R1 is a side chain of an alpha amino acid, R2 is an amino protecting group and R3 and R4 are independently either hydrogen or C1-4-alkyl, and R5 is hydrogen or methyl starting from an amino acid derivative of the formula wherein R1 and R2 are as defined above. Pseudo proline dipeptides can be used as reversible protecting groups for Ser, Thr and Cys and thus are versatile tools in peptide chemistry.

Abstract: In order to additionally develop a forming device for delivering at least one root shielding gas to the root side of at least one region to be joined of at least one object, as well as a corresponding method, such that discolorations and the formation of coatings on the object to be joined are effectively prevented, the invention proposes that the delivered root shielding gas is directed, and guided or deflected in the direction along the root side of the region to be joined.

Abstract: A method for electric arc joining, in particular for arc welding and/or arc soldering, under protective gas using the method of T[ungsten] l[nert] G[as] joining, in particular TIG welding and/or TIG soldering, at least one gas mixture having the composition essentially argon and/or helium and carbon dioxide in a proportion range from approximately 0.2 volume-percent (vol.-%) to approximately 0.7 vol.-% being supplied as the protective gas, as well as a corresponding protective gas, in such a manner that weld pool movements, electric arc turbulence, and occurrences of wear of the T[ungsten] l[nert] G[as] electrode may be reliably avoided. The protective gas also has hydrogen in a proportion range from approximately 1.8 vol.-% to approximately 9 vol.-%.

Abstract: This invention provides a method for on-site production of a protective gas mixture for arc joining, in particular for arc welding. Gaseous argon is removed from a liquid argon supply and helium is added to the argon, and a doping gas premix which is prepared separately on-site is added. Various combinations of argon, helium and the doping gas premix are supplied via a protective gas supply device which supplies multiple workplaces with different gas mixtures without the need for specialty gas mixing equipment.

Abstract: Disclosed is a process for the manufacture of pseudo proline dipeptides of the formula wherein R1 is a side chain of an alpha amino acid, R2 is an amino protecting group and R3 and R4 are independently either hydrogen or C1-4-alkyl, and R5 is hydrogen or methyl starting from an amino acid derivative of the formula wherein R1 and R2 are as defined above. Pseudo proline dipeptides can be used as reversible protecting groups for Ser, Thr and Cys and thus are versatile tools in peptide chemistry.

Abstract: A protective gas supply device for on-site supply of workplaces is provided, in which a liquid argon reservoir, a liquid oxygen reservoir or a liquid carbon dioxide reservoir, and a helium supply are connected to first and second mixers supplying gas to site workplaces. The liquid argon reservoir and the liquid oxygen or carbon dioxide reservoir are connected to the feed side of the first mixer via lines, and the discharge side of the first mixer is connected to at least one workplace and to the feed side of a second mixer. The feed side of the second mixer also receives helium from the helium supply, and the discharge side of the second mixer is connected to at least one additional workplace. The invention permits economical mixing and supply of variable protective gas mixtures to work stations in an on-site environment.

Abstract: This invention relates to stable pharmaceutical compositions of 5,10-methylene-(6R)-, -(65)- or -(6R,S)-tetrahydrofolate by adjusting to a basic pH and the simultaneous use of citrate. Stabilisation is effected even in the absence of a reducing agent. The present invention is particularly suitable for producing lyophilisation solutions and lyophilisates or dry powders and dry mixtures, since the stable MTHF solutions can be used in high concentrations for filling corresponding vessels such as phials, ampoules, etc. The lyophilisates have a surprisingly long shelf life and are surprisingly stable. They can be reconstituted without problems by adding water or aqueous solutions, and the final clear injection solutions again exhibit excellent stability properties. Moreover, the present invention even makes it possible to prepare difficultly soluble calcium or acidic salts of MTHF in high concentrations and as physiologically compatible isotonic solutions.

Abstract: The invention relates to a shielding gas for use in the arc welding of metallic work pieces. The invention further relates to a process for the arc welding of metallic work pieces using consumable electrodes, whereby a shielding gas stream is supplied to the work piece adjacent to the electrode. According to the invention, for shielding gases recommended for use in the MSG welding, preferably the MAG welding, of rust-proof steels, especially nickel-based materials, specialty steels, or high-alloy steels, a) if the shielding gas contains no helium, it contains carbon dioxide in a proportion of between 0.001% by volume and 1.9% by volume and b) if the shielding gas does contain helium, it contains carbon dioxide in a proportion of between 0.001% by volume and 0.9% by volume, in addition to argon, nitrogen, and, if applicable, helium.

Abstract: A protective gas supply device for on-site supply of workplaces is provided, in which a liquid argon reservoir, a liquid oxygen reservoir or a liquid carbon dioxide reservoir, and a helium supply are connected to first and second mixers supplying gas to site workplaces. The liquid argon reservoir and the liquid oxygen or carbon dioxide reservoir are connected to the feed side of the first mixer via lines, and the discharge side of the first mixer is connected to at least one workplace and to the feed side of a second mixer. The feed side of the second mixer also receives helium from the helium supply, and the discharge side of the second mixer is connected to at least one additional workplace. The invention permits economical mixing and supply of variable protective gas mixtures to work stations in an on-site environment.

Abstract: This invention provides a method for on-site production of a protective gas mixture for arc joining, in particular for arc welding. Gaseous argon is removed from a liquid argon supply and helium is added to the argon, and a doping gas premix which is prepared separately on-site is added. Various combinations of argon, helium and the doping gas premix are supplied via a protective gas supply device which supplies multiple workplaces with different gas mixtures without the need for specialty gas mixing equipment.

Abstract: The invention relates to a shielding gas for use in the arc welding of metallic work pieces. The invention further relates to a process for the arc welding of metallic work pieces using consumable electrodes, whereby a shielding gas stream is supplied to the work piece adjacent to the electrode. According to the invention, for shielding gases recommended for use in the MSG welding, preferably the MAG welding, of rust-proof steels, especially nickel-based materials, specialty steels, or high-alloy steels, a) if the shielding gas contains no helium, it contains carbon dioxide in a proportion of between 0.001 % by volume and 1.9 % by volume and b) if the shielding gas does contain helium, it contains carbon dioxide in a proportion of between 0.001 % by volume and 0.9 % by volume, in addition to argon, nitrogen, and, if applicable, helium.

Abstract: The invention relates to a shielding gas for use in the arc welding of metallic work pieces. The invention further relates to a process for the arc welding of metallic work pieces using consumable electrodes, whereby a shielding gas stream is supplied to the work piece adjacent to the electrode.

Abstract: The invention relates to a shielding gas for use in the arc welding of metallic work pieces. The invention further relates to a process for the arc welding of metallic work pieces using consumable electrodes, whereby a shielding gas stream is supplied to the work piece adjacent to the electrode.

Abstract: Pure and extremely stable crystalline (6R)-tetrahydrofolic acids, absolutely inert even when exposed to air and elevated temperature without stabilizers being added, are prepared by a crystallization process at a pH of ≧2.

Abstract: Pure and extremely stable crystalline (6S)- and (6R)-tetrahydrofolic acids, absolutely inert even when exposed to air and elevated temperature without stabilizers being added, are prepared by a crystallization process at a pH of ≧3.5 for the preparation of crystalline (6S)-tetrahydrofolic acid and at a pH of ≧2 for the preparation of crystalline (6R)-tetrahydrofolic acid.

Abstract: Pure and extremely stable crystalline (6S)- and (6R)-tetrahydrofolic acids, absolutely inert even when exposed to air and elevated temperature without stabilizers being added, are prepared by a crystallization process at a pH of ≧3.5 for the preparation of crystalline (6S)-tetrahydrofolic acid and at a pH of ≧2 for the preparation of crystalline (6R)-tetrahydrofolic acid.

Abstract: This invention relates to stable crystalline salts of (6R,S)-, (6S)- and (6R)-tetrahydrofolic acid, to methods of preparing these salts and to their use as an ingredient for the production of drugs and pharmaceutical preparations.